Previous studies have linked the histological grade of PTB to molecular abnormalities, such as TERT promoter mutations, MED12 mutations, p53 expression abnormalities, and Wnt/β-catenin pathway activation, which may accumulate over time and promote tumor progression (10, 11). This evidence concerns the gene MED12 and neoplasm.